Published in Biotech Week, November 16th, 2011
"Noteworthy, current two phase III trials of cabazitaxel and sipuleucel-T...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.